Nanoparticle Delivery of Fidgetin siRNA as a Microtubule-based Therapy to Augment Nerve Regeneration

Timothy O. Austin, Andrew J. Matamoros, Joel M. Friedman, Adam J. Friedman, Parimala Nacharaju, Wenqian Yu, David J. Sharp, Peter W. Baas

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Microtubule-stabilizing drugs have gained popularity for treating injured adult axons, the rationale being that increased stabilization of microtubules will prevent the axon from retracting and fortify it to grow through inhibitory molecules associated with nerve injury. We have posited that a better approach would be not to stabilize the microtubules, but to increase labile microtubule mass to levels more conducive to axonal growth. Recent work on fetal neurons suggests this can be accomplished using RNA interference to reduce the levels of fidgetin, a microtubule-severing protein. Methods to introduce RNA interference into adult neurons, in vitro or in vivo, have been problematic and not translatable to human patients. Here we show that a novel nanoparticle approach, previously shown to deliver siRNA into tissues and organs, enables siRNA to gain entry into adult rat dorsal root ganglion neurons in culture. Knockdown of fidgetin is partial with this approach, but sufficient to increase the labile microtubule mass of the axon, thereby increasing axonal growth. The increase in axonal growth occurs on both a favorable substrate and a growth-inhibitory molecule associated with scar formation in injured spinal cord. The nanoparticles are readily translatable to in vivo studies on animals and ultimately to clinical applications.

Original languageEnglish (US)
Article number9675
JournalScientific Reports
Volume7
Issue number1
DOIs
StatePublished - Dec 1 2017

Fingerprint

Nerve Regeneration
Microtubules
Nanoparticles
Small Interfering RNA
Axons
Growth
RNA Interference
Neurons
Microtubule Proteins
Therapeutics
Spinal Ganglia
Cicatrix
Spinal Cord
Wounds and Injuries
Pharmaceutical Preparations

ASJC Scopus subject areas

  • General

Cite this

Nanoparticle Delivery of Fidgetin siRNA as a Microtubule-based Therapy to Augment Nerve Regeneration. / Austin, Timothy O.; Matamoros, Andrew J.; Friedman, Joel M.; Friedman, Adam J.; Nacharaju, Parimala; Yu, Wenqian; Sharp, David J.; Baas, Peter W.

In: Scientific Reports, Vol. 7, No. 1, 9675, 01.12.2017.

Research output: Contribution to journalArticle

Austin, Timothy O. ; Matamoros, Andrew J. ; Friedman, Joel M. ; Friedman, Adam J. ; Nacharaju, Parimala ; Yu, Wenqian ; Sharp, David J. ; Baas, Peter W. / Nanoparticle Delivery of Fidgetin siRNA as a Microtubule-based Therapy to Augment Nerve Regeneration. In: Scientific Reports. 2017 ; Vol. 7, No. 1.
@article{b252f3f8bf2f4146b7c2bf06e42ce210,
title = "Nanoparticle Delivery of Fidgetin siRNA as a Microtubule-based Therapy to Augment Nerve Regeneration",
abstract = "Microtubule-stabilizing drugs have gained popularity for treating injured adult axons, the rationale being that increased stabilization of microtubules will prevent the axon from retracting and fortify it to grow through inhibitory molecules associated with nerve injury. We have posited that a better approach would be not to stabilize the microtubules, but to increase labile microtubule mass to levels more conducive to axonal growth. Recent work on fetal neurons suggests this can be accomplished using RNA interference to reduce the levels of fidgetin, a microtubule-severing protein. Methods to introduce RNA interference into adult neurons, in vitro or in vivo, have been problematic and not translatable to human patients. Here we show that a novel nanoparticle approach, previously shown to deliver siRNA into tissues and organs, enables siRNA to gain entry into adult rat dorsal root ganglion neurons in culture. Knockdown of fidgetin is partial with this approach, but sufficient to increase the labile microtubule mass of the axon, thereby increasing axonal growth. The increase in axonal growth occurs on both a favorable substrate and a growth-inhibitory molecule associated with scar formation in injured spinal cord. The nanoparticles are readily translatable to in vivo studies on animals and ultimately to clinical applications.",
author = "Austin, {Timothy O.} and Matamoros, {Andrew J.} and Friedman, {Joel M.} and Friedman, {Adam J.} and Parimala Nacharaju and Wenqian Yu and Sharp, {David J.} and Baas, {Peter W.}",
year = "2017",
month = "12",
day = "1",
doi = "10.1038/s41598-017-10250-z",
language = "English (US)",
volume = "7",
journal = "Scientific Reports",
issn = "2045-2322",
publisher = "Nature Publishing Group",
number = "1",

}

TY - JOUR

T1 - Nanoparticle Delivery of Fidgetin siRNA as a Microtubule-based Therapy to Augment Nerve Regeneration

AU - Austin, Timothy O.

AU - Matamoros, Andrew J.

AU - Friedman, Joel M.

AU - Friedman, Adam J.

AU - Nacharaju, Parimala

AU - Yu, Wenqian

AU - Sharp, David J.

AU - Baas, Peter W.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Microtubule-stabilizing drugs have gained popularity for treating injured adult axons, the rationale being that increased stabilization of microtubules will prevent the axon from retracting and fortify it to grow through inhibitory molecules associated with nerve injury. We have posited that a better approach would be not to stabilize the microtubules, but to increase labile microtubule mass to levels more conducive to axonal growth. Recent work on fetal neurons suggests this can be accomplished using RNA interference to reduce the levels of fidgetin, a microtubule-severing protein. Methods to introduce RNA interference into adult neurons, in vitro or in vivo, have been problematic and not translatable to human patients. Here we show that a novel nanoparticle approach, previously shown to deliver siRNA into tissues and organs, enables siRNA to gain entry into adult rat dorsal root ganglion neurons in culture. Knockdown of fidgetin is partial with this approach, but sufficient to increase the labile microtubule mass of the axon, thereby increasing axonal growth. The increase in axonal growth occurs on both a favorable substrate and a growth-inhibitory molecule associated with scar formation in injured spinal cord. The nanoparticles are readily translatable to in vivo studies on animals and ultimately to clinical applications.

AB - Microtubule-stabilizing drugs have gained popularity for treating injured adult axons, the rationale being that increased stabilization of microtubules will prevent the axon from retracting and fortify it to grow through inhibitory molecules associated with nerve injury. We have posited that a better approach would be not to stabilize the microtubules, but to increase labile microtubule mass to levels more conducive to axonal growth. Recent work on fetal neurons suggests this can be accomplished using RNA interference to reduce the levels of fidgetin, a microtubule-severing protein. Methods to introduce RNA interference into adult neurons, in vitro or in vivo, have been problematic and not translatable to human patients. Here we show that a novel nanoparticle approach, previously shown to deliver siRNA into tissues and organs, enables siRNA to gain entry into adult rat dorsal root ganglion neurons in culture. Knockdown of fidgetin is partial with this approach, but sufficient to increase the labile microtubule mass of the axon, thereby increasing axonal growth. The increase in axonal growth occurs on both a favorable substrate and a growth-inhibitory molecule associated with scar formation in injured spinal cord. The nanoparticles are readily translatable to in vivo studies on animals and ultimately to clinical applications.

UR - http://www.scopus.com/inward/record.url?scp=85028454028&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85028454028&partnerID=8YFLogxK

U2 - 10.1038/s41598-017-10250-z

DO - 10.1038/s41598-017-10250-z

M3 - Article

C2 - 28852085

AN - SCOPUS:85028454028

VL - 7

JO - Scientific Reports

JF - Scientific Reports

SN - 2045-2322

IS - 1

M1 - 9675

ER -